Síndrome neuroléptico maligno: factores de riesgo y síntomas de alerta

Humarán Fernández, Ricardo; Díaz Valdés, Marta M; Hernández Elías, Heida.
Rev cienc méd pinar río ; 1(1)ene.-jun. 1997.
Artículo | CUMED | ID: cum-15894

Documentos relacionados

  1. Neuroleptic Malignant Syndrome in a 15-Month-Old Child: A Case Report.
  2. Prochlorperazine-induced neuroleptic malignant syndrome.
  3. Serotonin and neuroleptic malignant syndromes.
  4. Neuroleptic malignant syndrome: A case report.
  5. Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report.
  6. ATYPICAL NEUROLEPTIC MALIGNANT SYNDROME ASSOCIATED WITH MIRTAZAPINE USE.
  7. Neuroleptic Malignant Syndrome Associated With Lurasidone: A Case Report.
  8. A Validation Study of the International Consensus Diagnostic Criteria for Neuroleptic Malignant Syndrome.
  9. Concomitant neuroleptic malignant syndrome and diabetes insipidus.
  10. Diagnostic and therapeutic challenges in neuroleptic malignant syndrome: a severe medical case.